HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of vimentin in breast carcinoma, its correlation with Ki67 and other histopathological parameters.

AbstractCONTEXT:
Vimentin is a mesenchymal marker, known to express in some epithelial carcinomas.
AIMS:
1. To find out the expression of vimentin in infiltrating ductal carcinoma of breast (not otherwise specified), 2. To find out the correlation between expression of vimentin and prognostic markers such as tumor size, tumor grade, lymph node status, proliferation index (measured by Ki 67), and Nottingham prognostic index (NPI).
MATERIALS AND METHODS:
Study was done at Department of Pathology; 50 cases of infiltrating ductal carcinoma (NOS) were studied for tumor grade; immunohistochemistry was done using antibodies against vimentin and Ki 67. Percentages of positive cells were documented. An immunoscore was also calculated for vimentin. Vimentin expression was correlated with tumor size, lymph node status, Nottingham prognostic index, and Ki 67.
STATISTICAL ANALYSIS USED:
statistical correlation was done using Pearson's chi-square test. A P value less than 0.01 was considered significant.
RESULTS:
Vimentin expression was seen in 18% of cases. Its expression correlated with high tumor grade and high growth fraction (P value < 0.01). It did not correlate with lymph node status, tumor size, and NPI.
CONCLUSIONS:
Increased vimentin expression is associated with bad prognostic factors. Immunohistochemistry with vimentin may be helpful in knowing the prognosis in cases of infiltrating ductal carcinoma of breast (NOS).
AuthorsA Hemalatha, T N Suresh, M L Harendra Kumar
JournalIndian journal of cancer (Indian J Cancer) 2013 Jul-Sep Vol. 50 Issue 3 Pg. 189-94 ISSN: 1998-4774 [Electronic] India
PMID24061457 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Ki-67 Antigen
  • Vimentin
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (analysis)
  • Breast Neoplasms (metabolism, pathology)
  • Carcinoma, Ductal, Breast (metabolism, pathology)
  • Female
  • Humans
  • Immunohistochemistry
  • Ki-67 Antigen (analysis, biosynthesis)
  • Middle Aged
  • Neoplasm Grading
  • Prognosis
  • Retrospective Studies
  • Vimentin (analysis, biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: